Investment firms British Business Bank commits €25 million to EQT Life Science’s Health Economics 3 Fund dedicated to commercial stage medtech and digital health technologies Andera Partners raised €430 million for its Ander Expansion IV fund to invest in companies leading the way on ESG issues Asabys Partners joined The European Life Science Coalition (ELSC) as an Associate Member, alongside existing members Novo Holdings, Sofinnova Partners, […]
Lund, Sweden, June 12, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), is pleased to welcome investors and analysts to a Capital Markets Day on June 25, 2026. The Capital Markets Day will be held at The St. Regis Hotel, Two East 55th Street, at Fifth Avenue, New York, and will be broadcast live online. […]
As one of the organisers, Optimum is proud to partner with Anglonordic year on year to curate an awesome agenda for this fantastic event. Exclusively for European investors and R&D companies…
JPM 2026 was touted as the event that would usher in the best year in biotech in a long time. But when it happened there was a distinct lack of mega-deals to shout about. The elephant, you might say, was not in the room. Does this bode ill for 2026? Or is news of such […]
Highlighting Clinical Data and Discovery Platform Following Presentations at EASL Congress 2024 Edinburgh and London, UK, 13 June 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company developing macrophage cell therapies to treat end-stage liver disease, today announces that it will host a virtual R&D webinar on Friday 28th June 2024 at 12.30 BST / 7.30 […]
